Sustained low efficiency dialysis in the continuous mode (C-SLED): Dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 8, 2009, Pages 1338-1346

  Salahudeen, Abdulla K ^a   Kumar, Vikas ^a   Madan, Niti ^b   Xiao, Lianchun ^a   Lahoti, Amit ^a   Samuels, Joshua ^a,b   Nates, Joseph ^a   Price, Kristen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CITRIC ACID; CREATININE; DOBUTAMINE; DOPAMINE; HYPERTENSIVE FACTOR; NORADRENALIN; PHENYLEPHRINE; SERUM ALBUMIN; VASOPRESSIN; BIOLOGICAL MARKER; CREATINE;

ADULT; ARTICLE; BLOOD PH; CANCER PATIENT; CLEARANCE; CONTINUOUS HEMODIALYSIS; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DATA ANALYSIS; DRUG USE; FEMALE; HUMAN; HYPERNATREMIA; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; MULTIVARIATE ANALYSIS; NUTRITION; OLIGURIA; OUTCOME ASSESSMENT; PREDICTION; SCORING SYSTEM; SIDE EFFECT; SURVIVAL; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION; ULTRAFILTRATION; UNIVARIATE ANALYSIS; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY FAILURE; AGED; BLOOD; BLOOD PRESSURE; CRITICAL ILLNESS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEOPLASM; PATHOPHYSIOLOGY; PH; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD UREA NITROGEN; CREATINE; CRITICAL ILLNESS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEOPLASMS; PARENTERAL NUTRITION, TOTAL; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SERUM ALBUMIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 70349900573     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02130309     Document Type: Article

References (18)

1. Hoste EA, Schurgers M: Epidemiology of acute kidney injury: How big is the problem? Crit Care Med 36: S146-S151, 2008
2. Soares M, Salluh JI, Carvalho MS, Darmon M, Rocco JR, Spector N: Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 24: 4003-4010, 2006
3. Schlaeper C, Amerling R, Manns M, Levin NW: High clearance continuous renal replacement therapy with a modified dialysis machine. Kidney Int Suppl 72: S20-S23, 1999
4. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK: Sustained low-efficiency dialysis for critically ill pa-tients requiring renal replacement therapy. Kidney Int 60: 777-785, 2001
5. Tolwani AJ, Wheeler TS, Wille KM: Sustained low-efficiency dialysis. Contrib Nephrol 156: 320-324, 2007
6. Vincent JL, de Mendonca A, Cantraine F: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 26: 1793-1800, 1998
7. Berbece AN, Richardson RM: Sustained low-efficiency dialysis in the ICU: Cost, anticoagulation, and solute removal. Kidney Int 70: 963-968, 2006
8. Marshall MR, Ma T, Galler D, Rankin AP, Williams AB: Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: Towards an adequate therapy. Nephrol Dial Transplant 19: 877-884, 2004
9. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK: Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy. Am J Kidney Dis 39: 556-570, 2002
10. Zager RA, O'Quigley J, Zager BK: Acute renal failure following bone marrow transplantation: A retrospective study of 272 patients. Am J Kidney Dis 13: 210-216, 1989
11. Parikh CR, McSweeney P, Schrier RW: Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant. Kidney Int 67: 1999-2005, 2005
12. Wendon J, Smithies M, Sheppard M, Bullen K, Tinker J, Bihari D: Continuous high volume venous-venous haemofiltration in acute renal failure. Intensive Care Med 15: 358-363, 1989
13. Powell-Tuck J: Nutritional interventions in critical illness. Proc Nutr Soc 66: 16-24, 2007
14. Btaiche IF, Mohammad RA, Alaniz C, Mueller BA: Amino acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy. Pharmacotherapy 28: 600-613, 2008
15. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM: Amino acid and albumin losses during hemodialysis. Kidney Int 46: 830-837, 1994
16. Bellomo R, Martin H, Parkin G, Love J, Kearley Y, Boyce N: Continuous arteriovenous haemodiafiltration in the critically ill: Influence on major nutrient balances. Intensive Care Med 17: 399-402, 1991
17. Palevsky PM, Zhang JH, O'Connor TZ: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 7-20, 2008
18. Ronco C, Bellomo R, Homel P: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 356: 26-30, 2000